Patent · US Expired

Contrast agents

US6610269B1 · kind B1 · utility

40Cited by

3References

23Claims

0Family size

Assignee

Amersham Health AS · NO

Inventors

Jo Klaveness · Oslo, NO
Anne Naevestad · Oslo, NO
Helge Tolleshaug · Oslo, NO

Key dates

Filing date	Oct 22, 1999
Grant date	Aug 26, 2003
Priority date	—
Expiry date	Oct 22, 2019

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K51/1241
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides a composition of matter of the formula (I): V—L—R, where V is a vector moiety having affinity for an angiogenesis-related endothelias cell receptor, L is a linker moiety or a bond and R is a detectable moiety, characterized in that V is a non-peptidic organic group, or V is peptidic and R is a macromolecular or particulate species providing a multiplicity of labels detectable in in vivo imaging.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.